Department of Veterans Affairs pays for those drugs. The VA gets big discounts on drugs for a variety of reasons, deeper discounts than the state receives for the same drug in some cases. How truthful is the EpiPen ad put out by the Yes on Issue 2 campaign? Ohioans are now paying excessive prices for these drugs so if the VA pays a dollar for that pill then Ohio should pay a dollar for the pill," said Willard. The campaign in favor of the initiative, so far, according to campaign funding filings with the Ohio Secretary of State, has been funded completely by the California-based AIDS Healthcare Foundation.
The spokesperson for that campaign, Dale Butland, said that the ballot initiative may do the opposite of what it says it will do. Cleveland 19 reached out to a professor, who is not a lobbyist for either side, to get a more unbiased analysis of what the ballot initiative could mean. Mariana Carrera, an assistant professor of economics at Case Western Reserve University, said that there are a lot of variables at this point and it's difficult to predict exactly what will happen if it passes.
I would be skeptical that it would end up benefiting the taxpayer the way that the proponents think it would and that makes me a little wary to back a measure that would require a lot of bureaucratic hassle. For more information in favor: www.
The state government also negotiated drug prices, including for Ohio Medicaid. Issue 2 would have required state agencies and programs, not private insurance plans, to purchase prescription drugs for the same or lower prices than the VA. Borges said the initiative would have a "ripple effect through the marketplace," as consumers demand the government to require similar discounts in the private marketplace.
He also said Issue 2 would not increase drug prices for individuals and families with private healthcare. He stated, " You know why? Butland said the initiative would increase drug prices for consumers with private healthcare, as companies look to make up profits.
He stated, "If you tell a company, whether that company makes drugs or whether they make automobiles Section G of Issue 2 was designed to address legal defense of the measure. Ohioans Against the Deceptive Rx Issue, in a campaign fact sheet, said this provision of Issue 2 was unprecedented and would give promoters "the right to intervene at taxpayer expense in any legal challenges that may be filed against it if it becomes law.
This provision would give the sponsors a blank check to defend any part of the law, and require that their legal fees be reimbursed by taxpayers whether they win or lose.
Does Ohio Issue 2 give promoters the right to defend the law at taxpayer expense? October 4, Ohioans Against the Deceptive Rx Issue claims that the ballot initiative Issue 2 includes "an unprecedented provision granting [the promoters] the right to intervene at taxpayer expense in any legal challenges that may be filed against the measure. The official ballot title was as follows: [14].
The full text of the measure was as follows: [1]. In alone, total spending on specialty medications increased by more than 23 percent. This Act is necessary and appropriate to address these public concerns. The People of the State of Ohio hereby declare the following purposes and intent in enacting this Act:. In addition to agreements for any cash discounts, free goods, volume discounts, rebates, or any other discounts or credits already in place for these programs, the responsible department, agency or entity shall enter into additional agreements with drug manufacturers for further price reductions so that the net cost of the drug, as determined by the purchasing department, agency or entity, is the same as or less than the lowest price paid for the same drug by the United States Department of Veterans Affairs.
If any provision of this Act, or part thereof, or the applicability of any provision or part to any person or circumstances, is for any reason held to be invalid or unconstitutional, the remaining provisions and parts shall not be affected, but shall remain in full force and effect, and to this end the provisions and parts of this Act are severable.
If this Act and another law are approved by the voters at the same election with one or more conflicting provisions and this Act receives fewer votes, the non-conflicting provisions of this Act shall go into effect.
If any provision of this Act is challenged in court, it shall be defended by the Attorney General of Ohio. In the event of a challenge, any one or more of the Act's Proponents shall be entitled to assert their direct and personal stake by defending the Act's validity in any court of law, including on appeal.
The word count for the ballot title is , and the estimated reading time is 37 seconds. Each day, people are choosing between the basic necessities of life and paying for their medications. Ohio Taxpayers for Lower Drug Prices criticized the opposition campaign and contributors to the opposition campaign, stating: [29].
Despite being outspent by more than 5 to 1, Prop. Expect the drug industry to spend big in the fight against the Ohio drug price measure. These guys will stop at nothing to protect their ability to gouge Ohio taxpayers and patients.
In the California Prop. The drug industry can be expected to run its Ohio campaign like its California campaign: no news conferences, no transparency, just lots and lots of slick — and misleading — ads.
The following videos were Ohio Taxpayers for Lower Drug Prices' three campaign advertisements with the most views on Youtube, as of November 15, The opposition campaign listed the following organizations as coalition partners: [32].
The following organizations opposed Issue 2, but were not listed as coalition members on the opposition campaign's website:. Ohioans Against the Deceptive Rx Ballot Issue made the following argument against the initiative on the campaign's website: [32]. Experienced experts agree: the ballot proposal won't lower health care costs for Ohioans or save money for taxpayers. Experts say the measure would be nearly impossible to implement and will lead to more red tape and government bureaucracy.
Who is promoting Ohio Issue 2? The following videos were Ohioans Against the Deceptive Rx Ballot Issue's three campaign advertisements with the most views on Youtube, as of November 15, One ballot issue committee , Ohio Taxpayers for Lower Drug Prices, was registered in support of the initiative.
One ballot issue committee , Ohioans Against the Deceptive Rx Ballot Issue, was registered in opposition to the initiative. The measure was similar to California Proposition 61 , which spurred the most expensive ballot measure conflict of As of , Issue 2 was the most expensive ballot measure in Ohio state history. Amendment 3 was designed to authorize a casino. The following were contribution and expenditure totals for the committee in support of the initiative.
The following were the contribution and expenditure totals for the committee in opposition to the initiative. Ohio ballot measure committees filed a total of four campaign finance reports in The filing dates for reports were as follows: [46].
To read Ballotpedia's methodology for covering ballot measure campaign finance information, click here. If you are aware of any other editorials in support of Issue 2, please email it to editor ballotpedia.
According to Matt Borges, a consultant for the Issue 2 support campaign, polling in late October showed 42 percent of respondents in favor of the measure and 46 percent opposed. Ballotpedia does not have access to the details of the poll and, thus, cannot include it in the table below. Californians voted on Proposition 61 on November 8, The measure was defeated.
Department of Veterans Affairs pays for prescription drugs. The measure would have only applied to the purchasing of drugs by state agencies and not to purchases made by individuals. Issue 2 was similar to Proposition Professor Rachel E.
Sachs of the Washington University in St. The major difference between the two initiatives was that California Proposition 61 would have exempted from price regulation drugs purchased or procured under Medi-Cal Medicaid managed care programs. Ohio Issue 2 does not exempt from price regulation drugs purchased or procured under Ohio Medicaid managed care programs.
Medicaid managed care programs are insurance companies or networks of healthcare providers that contract with Medicaid to provide care for Medicaid recipients.
People who use Medicaid managed care programs must sign up for plans to receive services. For , Express Scripts Lab ESL , a branch of the nation's largest prescription-drug benefits administrator Express Scripts, calculated a fixed market baskets for the top 80 percent of utilized prescription drugs. In , ESL evaluated the value of each fixed market basket to determine whether the basket's value changed.
This analysis was continued each year through The Brand Prescription Price Index increased As we spelled out in editorials opposing the issue , it was confusing, unworkable and prone to expensive litigation that Ohio simply didn't need. Still, the death of Issue 2 -- which, if successful, would have been the nation's first voter-initiated law aimed at controlling drug prices -- should not spell the end of attempts to lower drug prices and curb the pharmaceutical industry's oversized market power.
That battle needs to be waged in Congress, where lawmakers are in a position to craft a national solution to a national problem that's exemplified by Big Pharma's ability to push up prices, untethered to reality, for life-saving drugs like the EpiPen.
Issue 2 ineptly chipped away at just a sliver of the problem. It claimed that it would reduce drug prices to state employees and others who get health care through the state by mandating the state match or beat the U. Department of Veteran Affairs' lowest drug prices.
Almost nobody could come to agreement on the facts of Issue 2's effects either. The No campaign said it was impossible to implement while simultaneously claiming it would lead to increased prices on the rest of Ohioans.
Weinstein, who also backed the initiative in California, said he wasn't deterred by the negative campaigning in the state. His organization plans to take similar initiatives to South Dakota and Washington, D. It was too early to determine if he would attempt the initiative in Ohio again, Weinstein said.
Laura Hancock contributed reporting from Columbus. Note to readers: if you purchase something through one of our affiliate links we may earn a commission. All rights reserved About Us. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local.
0コメント